BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 26849145)

  • 61. Roles of HTLV-1 basic Zip Factor (HBZ) in Viral Chronicity and Leukemic Transformation. Potential New Therapeutic Approaches to Prevent and Treat HTLV-1-Related Diseases.
    Mesnard JM; Barbeau B; Césaire R; Péloponèse JM
    Viruses; 2015 Dec; 7(12):6490-505. PubMed ID: 26690203
    [TBL] [Abstract][Full Text] [Related]  

  • 62. HTLV-1 Hbz protein, but not hbz mRNA secondary structure, is critical for viral persistence and disease development.
    Maksimova V; Wilkie T; Smith S; Phelps C; Melvin C; Yu L; Niewiesk S; Green PL; Panfil AR
    PLoS Pathog; 2023 Jun; 19(6):e1011459. PubMed ID: 37327244
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epigenetic silencing of HTLV-1 expression by the HBZ RNA through interference with the basal transcription machinery.
    Gazon H; Chauhan PS; Porquet F; Hoffmann GB; Accolla R; Willems L
    Blood Adv; 2020 Nov; 4(21):5574-5579. PubMed ID: 33170933
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.
    Tomita M; Kawakami H; Uchihara JN; Okudaira T; Masuda M; Takasu N; Matsuda T; Ohta T; Tanaka Y; Mori N
    Leuk Res; 2006 Mar; 30(3):313-21. PubMed ID: 16157375
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HTLV-1 bZIP Factor Impairs Anti-viral Immunity by Inducing Co-inhibitory Molecule, T Cell Immunoglobulin and ITIM Domain (TIGIT).
    Yasuma K; Yasunaga J; Takemoto K; Sugata K; Mitobe Y; Takenouchi N; Nakagawa M; Suzuki Y; Matsuoka M
    PLoS Pathog; 2016 Jan; 12(1):e1005372. PubMed ID: 26735971
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape.
    Vandermeulen C; O'Grady T; Wayet J; Galvan B; Maseko S; Cherkaoui M; Desbuleux A; Coppin G; Olivet J; Ben Ameur L; Kataoka K; Ogawa S; Hermine O; Marcais A; Thiry M; Mortreux F; Calderwood MA; Van Weyenbergh J; Peloponese JM; Charloteaux B; Van den Broeke A; Hill DE; Vidal M; Dequiedt F; Twizere JC
    PLoS Pathog; 2021 Sep; 17(9):e1009919. PubMed ID: 34543356
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The microRNA regulatory network in normal- and HTLV-1-transformed T cells.
    D'Agostino DM; Zanovello P; Watanabe T; Ciminale V
    Adv Cancer Res; 2012; 113():45-83. PubMed ID: 22429852
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy.
    Matsuoka M; Jeang KT
    Oncogene; 2011 Mar; 30(12):1379-89. PubMed ID: 21119600
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HTLV-1 bZIP factor impairs DNA mismatch repair system.
    Sakurada-Aono M; Sakamoto T; Kobayashi M; Takiuchi Y; Iwai F; Tada K; Sasanuma H; Hirabayashi S; Murakawa Y; Shirakawa K; Sakamoto C; Shindo K; Yasunaga JI; Matsuoka M; Pommier Y; Takeda S; Takaori-Kondo A
    Biochem Biophys Res Commun; 2023 May; 657():43-49. PubMed ID: 36972660
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia.
    Nakajima S; Okuma K
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511495
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Human T-cell lymphotropic virus HBZ and tax mRNA expression are associated with specific clinicopathological features in adult T-cell leukemia/lymphoma.
    Yamada K; Miyoshi H; Yoshida N; Shimono J; Sato K; Nakashima K; Takeuchi M; Arakawa F; Asano N; Yanagida E; Seto M; Ohshima K
    Mod Pathol; 2021 Feb; 34(2):314-326. PubMed ID: 32973330
    [TBL] [Abstract][Full Text] [Related]  

  • 72. HBZ, a new important player in the mystery of adult T-cell leukemia.
    Mesnard JM; Barbeau B; Devaux C
    Blood; 2006 Dec; 108(13):3979-82. PubMed ID: 16917009
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.
    Watanabe T; Yamashita S; Ureshino H; Kamachi K; Kurahashi Y; Fukuda-Kurahashi Y; Yoshida N; Hattori N; Nakamura H; Sato A; Kawaguchi A; Sueoka-Aragane N; Kojima K; Okada S; Ushijima T; Kimura S; Sueoka E
    Blood; 2020 Aug; 136(7):871-884. PubMed ID: 32391874
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Methods for Identifying and Examining HTLV-1 HBZ Post-translational Modifications.
    Al-Saleem J; Kvaratskhelia M; Green PL
    Methods Mol Biol; 2017; 1582():111-126. PubMed ID: 28357666
    [TBL] [Abstract][Full Text] [Related]  

  • 75. HTLV-1 bZIP factor supports proliferation of adult T cell leukemia cells through suppression of C/EBPα signaling.
    Zhao T; Coutts A; Xu L; Yu J; Ohshima K; Matsuoka M
    Retrovirology; 2013 Dec; 10():159. PubMed ID: 24359396
    [TBL] [Abstract][Full Text] [Related]  

  • 76. HTLV-1 induces T cell malignancy and inflammation by viral antisense factor-mediated modulation of the cytokine signaling.
    Higuchi Y; Yasunaga JI; Mitagami Y; Tsukamoto H; Nakashima K; Ohshima K; Matsuoka M
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13740-13749. PubMed ID: 32471947
    [TBL] [Abstract][Full Text] [Related]  

  • 77. c-Maf suppresses human T-cell leukemia virus type 1 Tax by competing for CREB-binding protein.
    Hieshima K; Nagakubo D; Shigeta A; Tanaka Y; Hoshino H; Tsukasaki K; Yamada Y; Yoshie O
    Cancer Sci; 2011 Apr; 102(4):890-4. PubMed ID: 21244576
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Decreased RORC expression and downstream signaling in HTLV-1-associated adult T-cell lymphoma/leukemia uncovers an antiproliferative IL17 link: A potential target for immunotherapy?
    Subramanian K; Dierckx T; Khouri R; Menezes SM; Kagdi H; Taylor GP; Farre L; Bittencourt A; Kataoka K; Ogawa S; Van Weyenbergh J
    Int J Cancer; 2019 Apr; 144(7):1664-1675. PubMed ID: 30303535
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Non-canonical translation initiation of the spliced mRNA encoding the human T-cell leukemia virus type 1 basic leucine zipper protein.
    Cáceres CJ; Angulo J; Lowy F; Contreras N; Walters B; Olivares E; Allouche D; Merviel A; Pino K; Sargueil B; Thompson SR; López-Lastra M
    Nucleic Acids Res; 2018 Nov; 46(20):11030-11047. PubMed ID: 30215750
    [TBL] [Abstract][Full Text] [Related]  

  • 80. HBZ stimulates brain-derived neurotrophic factor/TrkB autocrine/paracrine signaling to promote survival of human T-cell leukemia virus type 1-Infected T cells.
    Polakowski N; Terol M; Hoang K; Nash I; Laverdure S; Gazon H; Belrose G; Mesnard JM; Césaire R; Péloponèse JM; Lemasson I
    J Virol; 2014 Nov; 88(22):13482-94. PubMed ID: 25210182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.